Document Detail


TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model.
MedLine Citation:
PMID:  16461276     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Previous studies have demonstrated reexpression of cell-cycle markers within postmitotic neurons in neurodegenerative tauopathies, including Alzheimer's disease (AD). However, the critical questions of whether cell-cycle activation is causal or epiphenomenal to tau-induced neurodegeneration and which signaling pathways mediate cell-cycle activation in tauopathy remain unresolved. RESULTS: Cell-cycle activation accompanies wild-type and mutant tau-induced neurodegeneration in Drosophila, and genetically interfering with cell-cycle progression substantially reduces neurodegeneration. Our data support a role for cell-cycle activation downstream of tau phosphorylation, directly preceding apoptosis. We accordingly show that ectopic cell-cycle activation leads to apoptosis of postmitotic neurons in vivo. As in AD, TOR (target of rapamycin kinase) activity is increased in our model and is required for neurodegeneration. TOR activation enhances tau-induced neurodegeneration in a cell cycle-dependent manner and, when ectopically activated, drives cell-cycle activation and apoptosis in postmitotic neurons. CONCLUSIONS: TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model, identifying TOR and the cell cycle as potential therapeutic targets in tauopathies and AD.
Authors:
Vikram Khurana; Yiran Lu; Michelle L Steinhilb; Sean Oldham; Joshua M Shulman; Mel B Feany
Related Documents :
12749906 - Hydroquinone and catechol interfere with t cell cycle entry and progression through the...
16661676 - Control of pyrimidine biosynthesis in synchronously dividing cells of helianthus tubero...
15093536 - Crashing waves of destruction: the cell cycle and apc(cdh1) regulation of scf(skp2).
858696 - On the incremental lines in human dentine as revealed by tetracycline labeling.
16433906 - Increased therapeutic potential of an experimental anti-mitotic inhibitor sb715992 by g...
8483816 - Growth regulatory properties of endothelins.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Current biology : CB     Volume:  16     ISSN:  0960-9822     ISO Abbreviation:  Curr. Biol.     Publication Date:  2006 Feb 
Date Detail:
Created Date:  2006-02-07     Completed Date:  2006-12-04     Revised Date:  2010-02-01    
Medline Journal Info:
Nlm Unique ID:  9107782     Medline TA:  Curr Biol     Country:  England    
Other Details:
Languages:  eng     Pagination:  230-41     Citation Subset:  IM    
Affiliation:
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Harvard New Research Building Room 652, 77 Louis Pasteur Avenue, Boston, Massachusetts 02115, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
1-Phosphatidylinositol 3-Kinase / metabolism*
Animals
Apoptosis / physiology*
Blotting, Western
Cell Cycle / physiology*
Drosophila
Drosophila Proteins / metabolism*
Enzyme Activation / physiology
Immunohistochemistry
In Situ Nick-End Labeling
Neurons / cytology,  metabolism*
Signal Transduction / physiology*
Tauopathies / metabolism*,  physiopathology
Grant Support
ID/Acronym/Agency:
AG19790/AG/NIA NIH HHS; AG88001/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Drosophila Proteins; EC 2.7.1.-/target of rapamycin protein, Drosophila; EC 2.7.1.137/1-Phosphatidylinositol 3-Kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Convergent evolution of receptors for protein import into mitochondria.
Next Document:  Purified integrin adhesion complexes exhibit actin-polymerization activity.